Issue 2, 2011

Investigating the structural biofunctionality of antibodies conjugated to magnetic nanoparticles

Abstract

We present the synthesis of trastuzumab-functionalized pegylated iron oxide nanoparticles and provide an FTIR-based approach to gain a direct evidence of the actual conservation of the native structure of conjugated antibody. Their target-selectivity to specific cancer cell receptors has been also assessed.

Graphical abstract: Investigating the structural biofunctionality of antibodies conjugated to magnetic nanoparticles

Supplementary files

Article information

Article type
Communication
Submitted
23 Jun 2010
Accepted
03 Sep 2010
First published
29 Sep 2010

Nanoscale, 2011,3, 387-390

Investigating the structural biofunctionality of antibodies conjugated to magnetic nanoparticles

E. Occhipinti, P. Verderio, A. Natalello, E. Galbiati, M. Colombo, S. Mazzucchelli, A. Salvadè, P. Tortora, S. M. Doglia and D. Prosperi, Nanoscale, 2011, 3, 387 DOI: 10.1039/C0NR00436G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements